Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 834-838

  Zisa, David ^a   Shabbir, Arsalan ^a   Suzuki, Gen ^a   Lee, Techung ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Cell therapy; Heart failure; Mesenchymal stem cell; VEGF

Indexed keywords

VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FREE SYSTEM; CELL TRANSFORMATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HAMSTER; HEART FAILURE; HEART FUNCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MESENCHYME CELL; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; STEM CELL TRANSPLANTATION; TISSUE REGENERATION;

ANIMALS; BONE MARROW CELLS; CRICETINAE; CULTURE MEDIA, CONDITIONED; HEART; HEART FAILURE; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; REGENERATION; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

CRICETINAE; SUS;

EID: 70449705826     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.058     Document Type: Article

References (41)

1. Giordano A., Galderisi U., and Marino I.R. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J. Cell Physiol. 211 (2007) 27-35
2. Caplan A.I. Why are MSCs therapeutic? New data: new insight. J. Pathol. 217 (2009) 318-324
3. Prockop D.J. "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin. Pharmacol. Ther. 82 (2007) 241-243
4. Gnecchi M., Zhang Z., Ni A., and Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 103 (2008) 1204-1219
5. Kinnaird T., Stabile E., Burnett M.S., Lee C.W., Barr S., Fuchs S., and Epstein S.E. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 94 (2004) 678-685
6. Lee R.H., Pulin A.A., Seo M.J., Kota D.J., Ylostalo J., Larson B.L., Semprun-Prieto L., Delafontaine P., and Prockop D.J. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5 (2009) 54-63
7. Shabbir A., Zisa D., Suzuki G., and Lee T. Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a non-invasive therapeutic regimen. Am. J. Physiol. Heart Circ. Physiol. 296 (2009) H1888-H1897
8. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., Lanino E., Sundberg B., Bernardo M.E., Remberger M., Dini G., Egeler R.M., Bacigalupo A., Fibbe W., and Ringden O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371 (2008) 1579-1586
9. Tolar J., Nauta A.J., Osborn M.J., Panoskaltsis Mortari A., McElmurry R.T., Bell S., Xia L., Zhou N., Riddle M., Schroeder T.M., Westendorf J.J., McIvor R.S., Hogendoorn P.C., Szuhai K., Oseth L., Hirsch B., Yant S.R., Kay M.A., Peister A., Prockop D.J., Fibbe W.E., and Blazar B.R. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25 (2007) 371-379
10. Rubio D., Garcia-Castro J., Martin M.C., de la Fuente R., Cigudosa J.C., Lloyd A.C., and Bernad A. Spontaneous human adult stem cell transformation. Cancer Res. 65 (2005) 3035-3039
11. Rubio D., Garcia S., Paz M.F., De la Cueva T., Lopez-Fernandez L.A., Lloyd A.C., Garcia-Castro J., and Bernad A. Molecular characterization of spontaneous mesenchymal stem cell transformation. PLoS One 3 (2008) e1398
12. Burns J.S., Abdallah B.M., Guldberg P., Rygaard J., Schroder H.D., and Kassem M. Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res. 65 (2005) 3126-3135
13. Matushansky I., Hernando E., Socci N.D., Mills J.E., Matos T.A., Edgar M.A., Singer S., Maki R.G., and Cordon-Cardo C. Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J. Clin. Invest. 117 (2007) 3248-3257
14. Garderet L., Mazurier C., Chapel A., Ernou I., Boutin L., Holy X., Gorin N.C., Lopez M., Doucet C., and Lataillade J.J. Mesenchymal stem cell abnormalities in patients with multiple myeloma. Leuk. Lymphoma 48 (2007) 2032-2041
15. Wallace S.R., Oken M.M., Lunetta K.L., Panoskaltsis-Mortari A., and Masellis A.M. Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients. Cancer 91 (2001) 1219-1230
16. Shabbir A., Zisa D., Leiker M., Johnston C., Lin H., and Lee T. Muscular dystrophy therapy by non-autologous mesenchymal stem cells: muscle regeneration without immunosuppression and inflammation. Transplantation 87 (2009) 1275-1282
17. Lin H., Shabbir A., Molnar M., Yang J., Marion S., Canty J.M.J., and Lee T. Adenoviral expression of vascular endothelial growth factor splice variants differentially regulate bone marrow-derived mesenchymal stem cells. J. Cell Physiol. 216 (2008) 458-468
18. Missihoun C., Zisa D., Shabbir A., Lin H., and Lee T. Myocardial oxidative stress, osteogenic phenotype, and energy metabolism are differentially involved in the initiation and early progression of delta-sarcoglycan-null cardiomyopathy. Mol. Cell Biochem. 321 (2008) 45-52
19. Vacanti V., Kong E., Suzuki G., Sato K., Canty Jr. J.M., and Lee T. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J. Cell Physiol. 205 (2005) 194-201
20. Breitbach M., Bostani T., Roell W., Xia Y., Dewald O., Nygren J.M., Fries J.W., Tiemann K., Bohlen H., Hescheler J., Welz A., Bloch W., Jacobsen S.E., and Fleischmann B.K. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110 (2007) 1362-1369
21. Yoon Y.S., Park J.S., Tkebuchava T., Luedeman C., and Losordo D.W. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109 (2004) 3154-3157
22. Widimsky P., and Penicka M. Complications after intracoronary stem cell transplantation in idiopathic dilated cardiomyopathy. Int. J. Cardiol. 111 (2006) 178-179
23. Vulliet P.R., Greeley M., Halloran S.M., MacDonald K.A., and Kittleson M.D. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363 (2004) 783-784
24. Yla-Herttuala S., Rissanen T.T., Vajanto I., and Hartikainen J. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J. Am. Coll. Cardiol. 49 (2007) 1015-1026
25. Testa U., Pannitteri G., and Condorelli G.L. Vascular endothelial growth factors in cardiovascular medicine. J. Cardiovasc. Med. (Hagerstown) 9 (2008) 1190-1221
26. Lin H., Shabbir A., Molnar M., and Lee T. Stem cell regulatory function mediated by expression of a novel mouse Oct4 pseudogene. Biochem. Biophys. Res. Commun. 355 (2007) 111-116
27. Togel F., Zhang P., Hu Z., and Westenfelder C. VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J. Cell. Mol. Med. (2008)
28. Post M.J., Laham R., Sellke F.W., and Simons M. Therapeutic angiogenesis in cardiology using protein formulations. Cardiovasc. Res. 49 (2001) 522-531
29. D. Zisa, A. Shabbir, M. Mastri, G. Suzuki, T. Lee, Intramuscular VEGF repairs the failing heart: role of host derived growth factors and mobilization of progenitor cells, Am. J. Physiol. Regul. Integr. Comp. Physiol., in press.
30. Schwarz E.R., Speakman M.T., Patterson M., Hale S.S., Isner J.M., Kedes L.H., and Kloner R.A. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat - angiogenesis and angioma formation. J. Am. Coll. Cardiol. 35 (2000) 1323-1330
31. Lee R.J., Springer M.L., Blanco-Bose W.E., Shaw R., Ursell P.C., and Blau H.M. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102 (2000) 898-901
32. Crisan M., Yap S., Casteilla L., Chen C.W., Corselli M., Park T.S., Andriolo G., Sun B., Zheng B., Zhang L., Norotte C., Teng P.N., Traas J., Schugar R., Deasy B.M., Badylak S., Buhring H.J., Giacobino J.P., Lazzari L., Huard J., and Peault B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3 (2008) 301-313
33. Deasy B.M., Lu A., Tebbets J.C., Feduska J.M., Schugar R.C., Pollett J.B., Sun B., Urish K.L., Gharaibeh B.M., Cao B., Rubin R.T., and Huard J. A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J. Cell Biol. 177 (2007) 73-86
34. Ray R., Novotny N.M., Crisostomo P.R., Lahm T., Abarbanell A., and Meldrum D.R. Sex steroids and stem cell function. Mol. Med. 14 (2008) 493-501
35. Crisostomo P.R., Wang M., Herring C.M., Markel T.A., Meldrum K.K., Lillemoe K.D., and Meldrum D.R. Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1). J. Mol. Cell. Cardiol. 42 (2007) 142-149
36. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., Inai Y., Silver M., and Isner J.M. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18 (1999) 3964-3972
37. Zachary I., Mathur A., Yla-Herttuala S., and Martin J. Vascular protection: a novel nonangiogenic cardiovascular role for vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1512-1520
38. Song Y.H., Gehmert S., Sadat S., Pinkernell K., Bai X., Matthias N., and Alt E. VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes. Biochem. Biophys. Res. Commun. 354 (2007) 999-1003
39. Oswald J., Boxberger S., Jorgensen B., Feldmann S., Ehninger G., Bornhauser M., and Werner C. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22 (2004) 377-384
40. Iwaguro H., Yamaguchi J., Kalka C., Murasawa S., Masuda H., Hayashi S., Silver M., Li T., Isner J.M., and Asahara T. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105 (2002) 732-738
41. Wang X., Hu Q., Mansoor A., Lee J., Wang Z., Lee T., From A.H., and Zhang J. Bioenergetic and functional consequences of stem cell-based VEGF delivery in pressure-overloaded swine hearts. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H1393-H1405